Clinical Trials Directory

Trials / Completed

CompletedNCT05449587

Long-Term Effectiveness of the Motiva Implants® Round and Round Ergonomix

Study of the Long-Term Effectiveness of the Motiva Implants® Round and Round Ergonomix in Primary and Revision Breast Augmentation

Status
Completed
Phase
Study type
Observational
Enrollment
111 (actual)
Sponsor
Motiva USA LLC · Industry
Sex
Female
Age
Healthy volunteers
Accepted

Summary

Post-marketing surveillance study to demonstrate the silent rupture rate and satisfaction of patients who underwent a primary and revision breast augmentation surgery with Motiva Implants®, 3 to 10 years before enrollment.

Detailed description

Single-arm, multicenter study with a minimum of 160 subjects who underwent Breast Implant surgery from 3-10 years postoperatively. Following IRB / EC approval - and if applicable Competent Authority approval - Magnetic Resonance Imaging (MRI) and Patient-Reported Outcome (PRO) with the validated BREAST-Q will be collected at a single time point for all enrolled subjects. MRI data will be used for the analysis of silent rupture, and BREAST-Q Postoperative Augmentation module scales to record patients for satisfaction. Two styles of Motiva Implants® will be used for this study: * Motiva Implants® Silicone Gel-Filled Breast Implants, SmoothSilk® Round (referred to as "Motiva Implants® Round ProgressiveGel® Plus", or "Round") * Motiva Implants® Silicone Gel-Filled Breast Implants, SmoothSilk® Round Ergonomix® (referred to as "Motiva Implants® Ergonomix® Round ProgressiveGel® Ultima®", or "Round Ergonomix"). Henceforth, these devices will generally be referenced as "Motiva Implants®."

Conditions

Interventions

TypeNameDescription
OTHERMRI and PROMRI as a standard of care for the analysis of silent rupture. BREAST-Q Postoperative Augmentation module scales to record patients for satisfaction: Satisfaction with breasts; Satisfaction with outcome; Psychosocial well-being; Physical well-being

Timeline

Start date
2022-11-22
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2022-07-08
Last updated
2024-10-31

Locations

2 sites across 1 country: Costa Rica

Source: ClinicalTrials.gov record NCT05449587. Inclusion in this directory is not an endorsement.